Zagami P - Search Results

1

Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure.

Antonarelli G, Corti C, Tarantino P, Salimbeni BT, Zagami P, Marra A, Trapani D, Tolaney S, Cortes J, Curigliano G. Antonarelli G, et al. Among authors: zagami p. ESMO Open. 2023 Aug;8(4):101608. doi: 10.1016/j.esmoop.2023.101608. Epub 2023 Jul 17. ESMO Open. 2023. PMID: 37467660 Free PMC article. Review.

2

5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension.

Ravera M, Viazzi F, Berruti V, Leoncini G, Zagami P, Bezante GP, Rosatto N, Ravazzolo R, Pontremoli R, Deferrari G. Ravera M, et al. Among authors: zagami p. Am J Hypertens. 2001 Apr;14(4 Pt 1):371-6. doi: 10.1016/s0895-7061(00)01296-6. Am J Hypertens. 2001. PMID: 11336184

3

Carotid diameter, wall thickness, and parietal stress in essential hypertension.

Del Sette M, Zagami P, Angeli S, Finocchi C, Gandolfo C, Pontremoli R. Del Sette M, et al. Among authors: zagami p. Stroke. 1995 Dec;26(12):2373-4. Stroke. 1995. PMID: 7491669 No abstract available.

4

Increased renal resistive index in patients with essential hypertension: a marker of target organ damage.

Pontremoli R, Viazzi F, Martinoli C, Ravera M, Nicolella C, Berruti V, Leoncini G, Ruello N, Zagami P, Bezante GP, Derchi LE, Deferrari G. Pontremoli R, et al. Among authors: zagami p. Nephrol Dial Transplant. 1999 Feb;14(2):360-5. doi: 10.1093/ndt/14.2.360. Nephrol Dial Transplant. 1999. PMID: 10069189

5

What therapies are on the horizon for HER2 positive breast cancer?

Viale G, Morganti S, Ferraro E, Zagami P, Marra A, Curigliano G. Viale G, et al. Among authors: zagami p. Expert Rev Anticancer Ther. 2019 Sep;19(9):811-822. doi: 10.1080/14737140.2019.1660164. Epub 2019 Aug 28. Expert Rev Anticancer Ther. 2019. PMID: 31448640 Review.

6

Antibody-drug conjugates in breast cancer: the chemotherapy of the future?

Nicolò E, Zagami P, Curigliano G. Nicolò E, et al. Among authors: zagami p. Curr Opin Oncol. 2020 Sep;32(5):494-502. doi: 10.1097/CCO.0000000000000656. Curr Opin Oncol. 2020. PMID: 32657795 Review.

7

Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials.

Criscitiello C, Marra A, Morganti S, Zagami P, Viale G, Esposito A, Curigliano G. Criscitiello C, et al. Among authors: zagami p. Oncologist. 2020 Nov;25(11):e1732-e1742. doi: 10.1634/theoncologist.2020-0518. Epub 2020 Sep 18. Oncologist. 2020. PMID: 32785940 Free PMC article.

8

Management of Cardiac Toxicity Induced by Chemotherapy.

Trapani D, Zagami P, Nicolò E, Pravettoni G, Curigliano G. Trapani D, et al. Among authors: zagami p. J Clin Med. 2020 Sep 7;9(9):2885. doi: 10.3390/jcm9092885. J Clin Med. 2020. PMID: 32906611 Free PMC article. Review.

9

Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2.

Marra A, Generali D, Zagami P, Cervoni V, Gandini S, Venturini S, Morganti S, Passerini R, Orecchia R, Curigliano G. Marra A, et al. Among authors: zagami p. Ann Oncol. 2021 Jan;32(1):113-119. doi: 10.1016/j.annonc.2020.10.473. Epub 2020 Oct 21. Ann Oncol. 2021. PMID: 33098994 Free PMC article.

10

Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature.

Conforti F, Tarantino P, Trillo P, Pala L, Zagami P, Pirola S, Di Venosa B, Catania C, Queirolo P, Pennacchioli E, Della Vigna P, Curigliano G, De Pas TM. Conforti F, et al. Among authors: zagami p. Cancer Treat Rev. 2021 Jan;92:102133. doi: 10.1016/j.ctrv.2020.102133. Epub 2020 Dec 3. Cancer Treat Rev. 2021. PMID: 33296826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters